Correction: Genetic aetiologies for childhood speech disorder: novel pathways co-expressed during brain development

Correction to: Molecular Psychiatry 10.1038/s41380-022-01764-8, published online 18 September 2022

Wording was altered for the discussion.

Only two probands (11%) with genetic diagnoses (SETD1B (ID10), ERF (ID18)) had CAS without co-occurring neurodevelopmental disorder diagnoses. One was aged 10;8 years, had average IQ and was attending a school for children with specific speech and language impairment. The other child was only 4;7 years and had not yet had IQ testing because no concerns had been raised by his treating physician, family or preschool teacher regarding his general learning ability; however, it is possible that other neurodevelopmental diagnoses could still be made into the future. These findings expand the spectrum of phenotypes associated with these conditions. SETD1B has been previously associated with epilepsy, intellectual disability and language delay, and ERF-related craniosynostosis syndrome often includes speech and language delay, learning difficulties or behavioural problems; however variable expressivity and incomplete penetrance have previously been observed [40].

See attached files for table and figure changes.

Table 1

Table 3a

Fig. 3

Fig. 4

The original article has been corrected.